Advanced
search

To read this content please select one of the options below:

Nanotechnology and medical devices: Risk, regulation and ‘meta’ registration

Simon Grange 1 ,
Kris Chettiar 2 ,
Mateen Arestu 2 ,
Patrick Pilarski 3 ,
Peter Smitham 4 ,
Marilena Loizidou 5 ,
Gavin Jell 5
1 Alberta Bone and Joint Health Institute, Suite 400, 3820, Hospital Drive NW, Calgary, Canada
2 Dept of Surgery, University of Calgary, Canada
3 Dept. Computer Science, University of Alberta, Canada
4 Institute of Orthopaedics and Musculoskeletal Science (IOMS), Stanmore, UK
5 Dept. of Surgery, UCL, Royal Free Campus, London, UK

World Journal of Engineering

ISSN: 1708-5284

Article publication date: 12 July 2013

92

Abstract

A new approach to risk assessment for nanotechnology in healthcare includes the mapping of particles to risk profiles and the potential channels for the collection of relevant information. This relates assay type to processes probed and the recognition of the relevance of this to particle pathways. It is only by ensuring the sound regulation of this throughout the ‘life cycle’ of translational research and development, which we can ensure the true provenance of materials that we intend to use in the clinical environment.

Keywords

Citation

Grange, S., Chettiar, K., Arestu, M., Pilarski, P., Smitham, P., Loizidou, M. and Jell, G. (2013), "Nanotechnology and medical devices: Risk, regulation and ‘meta’ registration", World Journal of Engineering, Vol. 10 No. 3, pp. 191-198. https://doi.org/10.1260/1708-5284.10.3.191

Publisher

:

Emerald Group Publishing Limited

Related articles

Manage cookies

We’re listening — tell us what you think

Join us on our journey